# Atorvastatin in Myeloma

> **NCT00164086** · PHASE1 · UNKNOWN · sponsor: **Bayside Health**

## Conditions studied

- Myeloma

## Interventions

- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00164086
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164086, "Atorvastatin in Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00164086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*